Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

72.30
+2.683.85%
Post-market: 72.300.00000.00%16:15 EDT
Volume:61.10K
Turnover:4.35M
Market Cap:106.62M
PE:- -
High:72.44
Open:69.94
Low:69.80
Close:69.62
52wk High:72.44
52wk Low:40.17
Shares:1.47M
Float Shares:1.47M
Volume Ratio:1.62
T/O Rate:4.14%
Dividend:0.65
Dividend Rate:0.90%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Moderna Provides Details on Data Presentations at Upcoming Conferences

MT Newswires Live
·
Sep 22

Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares

Reuters
·
Sep 22

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

TIPRANKS
·
Sep 22

Moderna Inc Stock (MRNA) Moved Up by 14.21% on Sep 21: Drivers Behind the Movement

TradingKey
·
Sep 22

Moderna Stock Jumps. Its mRNA Cancer Vaccine is Getting Ready for Its Next Big Test.

Dow Jones
·
Sep 22

Moderna to Present Late-Breaking Phase 3 Melanoma Data for Intismeran Autogene at ESMO 2026

Reuters
·
Sep 22

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 22

Moderna announces late-breaking data to be presented at ESMO Congress 2026

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

Electra Therapeutics indicated to open at $20, IPO priced at $15

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Natera Says Lung Cancer MRD Study Links Signatera Results to 3-Year Recurrence-Free Survival in 1,129 Patients

Reuters
·
Sep 18

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

Reuters
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Sep 18

Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled

TradingKey
·
Sep 18

FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A

TIPRANKS
·
Sep 18

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

TradingKey
·
Sep 18